Selected article for: "CNS damage and immune cns system"
Author: Mohammadi, Soheil; Moosaie, Fatemeh; Aarabi, Mohammad Hadi
Title: Understanding the Immunologic Characteristics of Neurologic Manifestations of SARS-CoV-2 and Potential Immunological Mechanisms
  • Cord-id: otxpc46a
  • Document date: 2020_9_1
    • ID: otxpc46a
    Snippet: Similar to its predecessors, coronavirus disease 2019 (COVID-19) exhibits neurotrophic properties, which lead to progression of neurologic sequelae. Besides direct viral invasion to the central nervous system (CNS), indirect CNS involvement through viral-mediated immune response is plausible. Aberrant immune pathways such as extreme release of cytokines (cytokine storm), autoimmunity mediated by cross-reactivity between CNS components and viral particles, and microglial activation propagate CNS
    Document: Similar to its predecessors, coronavirus disease 2019 (COVID-19) exhibits neurotrophic properties, which lead to progression of neurologic sequelae. Besides direct viral invasion to the central nervous system (CNS), indirect CNS involvement through viral-mediated immune response is plausible. Aberrant immune pathways such as extreme release of cytokines (cytokine storm), autoimmunity mediated by cross-reactivity between CNS components and viral particles, and microglial activation propagate CNS damage in these patients. Here, we review the currently available evidence to discuss the plausible immunologic pathways that may contribute to the development of COVID-19 neurological complications, namely Alzheimer’s disease, Parkinson’s disease, stroke, multiple sclerosis, Guillain-Barre syndrome, seizure, and brainstem involvement.

    Search related documents:
    Co phrase search for related documents
    • acute stage and lupus anticoagulant: 1
    • acute stage and magnetic resonance: 1, 2, 3
    • ad disease and ad lead neurodegeneration: 1
    • ad disease and adaptive immune response: 1
    • ad disease and adaptive immune response innate: 1
    • ad disease and long period: 1, 2, 3
    • ad disease and lymphocyte macrophage: 1
    • ad disease and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • adaptive immune response innate and local inflammation: 1
    • long term short term and magnetic resonance: 1, 2, 3